NASDAQ, LIFE - Atyr Pharma Inc
We began operations as a California partnership in 1987 and incorporated in
California in 1989. In 1997 we reincorporated as a Delaware corporation. Our
principal offices are in Carlsbad, California. Our website is
http://www.invitrogen.com. This Annual Report on Form 10-K, our Quarterly
Reports on Form 10-Q, our Current Reports on Form 8-K and any amendments thereto
are made available without charge on our website.
We have made a number of significant acquisitions over the past several years
that have expanded our overall size and the breadth of the products we offer,
including the 2007 acquisition of Cascade Biologics, Inc. and Genomed GmbH, the
2006 acquisition of Sentigen Holding Corp. and the asset purchase of Xcyte
Therapies, Inc. (Xcyte), and the 2005 acquisitions of Dynal Biotech Holding AS
(Dynal), BioSource International, Inc. (BioSource), Caltag Laboratories (Caltag)
and Zymed Laboratories, Inc. (Zymed). ...
Read SEC Filing on NASDAQ.com »